A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Johnson, Melissa L, Patel, Manish R, Aljumaily, Raid, Jones, Suzanne F, Burris, III, Howard A, Spigel, David R
Published in The oncologist (Dayton, Ohio) (01.07.2023)
Published in The oncologist (Dayton, Ohio) (01.07.2023)
Get full text
Journal Article
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
Girish, Sandhya, Gupta, Manish, Wang, Bei, Lu, Dan, Krop, Ian E., Vogel, Charles L., Burris III, Howard A., LoRusso, Patricia M., Yi, Joo-Hee, Saad, Ola, Tong, Barbara, Chu, Yu-Waye, Holden, Scott, Joshi, Amita
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Get full text
Journal Article
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
Yardley, Denise A., Bosserman, Linda D., O’Shaughnessy, Joyce A., Harwin, William N., Morgan, Susan K., Priego, Victor M., Peacock, Nancy W., Bass, J. David, Burris III, Howard A., Hainsworth, John D.
Published in Breast cancer research and treatment (01.11.2015)
Published in Breast cancer research and treatment (01.11.2015)
Get full text
Journal Article
Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors
Infante, Jeffrey R., Keedy, Vicki L., Jones, Suzanne F., Zamboni, William C., Chan, Emily, Bendell, Johanna C., Lee, Wooin, Wu, Huali, Ikeda, Satoshi, Kodaira, Hiroshi, Rothenberg, Mace L., Burris III, Howard A.
Published in Cancer chemotherapy and pharmacology (01.11.2012)
Published in Cancer chemotherapy and pharmacology (01.11.2012)
Get full text
Journal Article
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer
Lu, Dan, Burris, 3rd, Howard A, Wang, Bei, Dees, E Claire, Cortes, Javier, Joshi, Amita, Gupta, Manish, Yi, Joo-Hee, Chu, Yu-Waye, Shih, Ted, Fang, Liang, Girish, Sandhya
Published in Current drug metabolism (01.09.2012)
Published in Current drug metabolism (01.09.2012)
Get more information
Journal Article
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine
Infante, Jeffrey R., Jones, Suzanne F., Bendell, Johanna C., Greco, F. Anthony, Yardley, Denise A., Lane, Cassie M., Spigel, David R., Hainsworth, John D., Burris III, Howard A.
Published in Cancer chemotherapy and pharmacology (2012)
Published in Cancer chemotherapy and pharmacology (2012)
Get full text
Journal Article
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
BURRIS, Howard A, RUGO, Hope S, AMLER, Lukas, MAOXIA ZHENG, CHU, Yu-Waye, KLENCKE, Barbara, O'SHAUGHNESSY, Joyce A, VUKELJA, Svetislava J, VOGEL, Charles L, BORSON, Rachel A, LIMENTANI, Steven, TAN-CHIU, Elizabeth, KROP, Ian E, MICHAELSON, Richard A, GIRISH, Sandhya
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
Variable detection of actionable alterations across racial groups and association with testing patterns
Sturgill, Emma, Correia, Jessica, Schumacher, Cooper, Luckett, Daniel, Jones, Suzanne Fields, Burris III, Howard A., Spigel, David R., McKenzie, Andrew Jacob
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
Arnold Egloff, Shanna A, Junglen, Angela, Restivo, Joseph Sa, Wongskhaluang, Marjorie, Martin, Casey, Doshi, Pratik, Schlauch, Daniel, Fromell, Gregg, Sears, Lindsay E, Correll, Mick, Burris, 3rd, Howard A, LeMaistre, Charles F
Published in The Journal of clinical investigation (15.10.2021)
Published in The Journal of clinical investigation (15.10.2021)
Get full text
Journal Article
Concordance of blood and tissue TMB from NGS testing in real-world settings and their ability to predict response to immunotherapy
Sturgill, Emma, Misch, Amanda, Jones, Carissa, Luckett, Daniel, Fu, Xiaotong, Jones, Suzanne Fields, Burris III, Howard A., Spigel, David R., McKenzie, Andrew Jacob
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study
Burris, 3rd, H A, Vogel, C L, Castro, D, Mishra, L, Schwarz, M, Spencer, S, Oakes, D D, Korey, A, Orenberg, E K
Published in Otolaryngology-head and neck surgery (01.04.1998)
Published in Otolaryngology-head and neck surgery (01.04.1998)
Get more information
Journal Article
Real-world data evaluating immunotherapy markers and checkpoint inhibitor response among GI cancers in a large community-based oncology network
Jones, Carissa, Lachs, Rebecca, Sturgill, Emma, Misch, Amanda, Lietman, Caressa, Jones, Suzanne Fields, Burris III, Howard A., Sen, Shiraj, Bendell, Johanna C.
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Patient-reported outcomes for the phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer
Burris III, Howard A., Okusaka, Takuji, Vogel, Arndt, Lee, Myung Ah, Takahashi, Hidenori, Breder, Valeriy Vladimirovich, Blanc, Jean-Frédéric, Li, Junhe, Watras, Magdalena, Xiong, Julia, Abraham, Jayne, Patel, Nikunj, Wang, Julie, Rokutanda, Nana, Cohen, Gordon, Oh, Do-Youn
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors
O'DONNELL, Anne, FAIVRE, Sandrine, BROCK, Cathryn, JONES, Suzanne, RAYMOND, Eric, JUDSON, Ian, BURRIS, Howard A, REA, Daniel, PAPADIMITRAKOPOULOU, Vassiliki, SHAND, Nicholas, LANE, Heidi A, HAZELL, Katharine, ZOELLNER, Ulrike, KOVARIK, John M
Published in Journal of clinical oncology (01.04.2008)
Published in Journal of clinical oncology (01.04.2008)
Get full text
Journal Article
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
SOBRERO, Alberto F, MAUREL, Joan, LENZ, Heinz-Josef, BORG, Christophe, MIDDLETON, Gary, KRÖNING, Hendrik, LUPPI, Gabriele, KISKER, Oliver, ZUBEL, Angela, LANGER, Christiane, KOPIT, Justin, BURRIS, Howard A, FEHRENBACHER, Louis, SCHEITHAUER, Werner, ABUBAKR, Yousifa, LUTZ, Manfred P, VEGA-VILLEGAS, M. Eugenia, ENG, Cathy, STEINHAUER, Ernst U, PRAUSOVA, Jana
Published in Journal of clinical oncology (10.05.2008)
Published in Journal of clinical oncology (10.05.2008)
Get full text
Journal Article
Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
KHAMBATA-FORD, Shirin, GARRETT, Christopher R, TAN, Benjamin R, KRISHNAMURTHI, Smitha S, BURRIS, Howard A, POPLIN, Elizabeth A, HIDALGO, Manuel, BASELGA, Jose, CLARK, Edwin A, MAURO, David J, MEROPOL, Neal, BASIK, Mark, HARBISON, Christopher T, SHUJIAN WU, WONG, Tai W, XIN HUANG, TAKIMOTO, Chris H, GODWIN, Andrew K
Published in Journal of clinical oncology (01.08.2007)
Published in Journal of clinical oncology (01.08.2007)
Get full text
Journal Article
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
Sturgill, Emma G, Misch, Amanda, Jones, Carissa C, Luckett, Daniel, Fu, Xiaotong, Schlauch, Dan, Jones, Suzanne F, Burris, Howard A, Spigel, David R, McKenzie, Andrew J
Published in The oncologist (Dayton, Ohio) (11.03.2022)
Published in The oncologist (Dayton, Ohio) (11.03.2022)
Get full text
Journal Article
Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer
Bouattour, Mohamed, Valle, Juan W., Vogel, Arndt, Kim, Jin Won, Kitano, Masayuki, Chen, Jen-Shi, Burris III, Howard A., Zaucha, Renata, Qin, Shukui, Evesque, Ludovic, Zhen, David Bing, Gupta, Vineet Govinda, Park, Joon Oh, Żotkiewicz, Magdalena, Rokutanda, Nana, Cohen, Gordon, Oh, Do-Youn
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article